
Gesund.ai provides a comprehensive platform for medical AI developers to establish, optimize, and sustain their AI lifecycles, ensuring privacy, compliance, speed, and scalability. Their offerings include AI CRO for independent validation studies and AI Factory for supercharging in-house AI model R&D. Customers like ScanDiags and Trillium Health Partners have reported significant improvements in speed and cost-effectiveness, with ScanDiags noting a 4X speed and 2X cost improvement compared to traditional validation methods. The company aims to bring clinical-grade AI solutions to market by auditing and validating third-party medical AI solutions for safety, effectiveness, and equity.

Gesund.ai provides a comprehensive platform for medical AI developers to establish, optimize, and sustain their AI lifecycles, ensuring privacy, compliance, speed, and scalability. Their offerings include AI CRO for independent validation studies and AI Factory for supercharging in-house AI model R&D. Customers like ScanDiags and Trillium Health Partners have reported significant improvements in speed and cost-effectiveness, with ScanDiags noting a 4X speed and 2X cost improvement compared to traditional validation methods. The company aims to bring clinical-grade AI solutions to market by auditing and validating third-party medical AI solutions for safety, effectiveness, and equity.
What they do: Provides an AI governance and assurance platform (GDAP) for regulated medical AI covering development, independent validation, deployment, monitoring, and regulatory evidence
Founded / HQ: Founded 2021; headquartered in Cambridge, Massachusetts
Founder / CEO: Dr. Enes Hosgor
Employees: ~17
Known funding: $3,150,000 total (records include a $2.0M pre-seed announced Feb 24, 2022)
Regulated medical AI—validation, governance, deployment, post-market monitoring, and regulatory evidence generation.
2021
Healthcare / Medical AI / AI governance
$2,000,000
Pre-seed round announced Feb 24, 2022
Listed funding-related event on this date described as non-equity assistance in public records
“Includes early-stage venture and strategic investors such as 500 Global, Merck Digital Sciences Studio, CancerX Startup Accelerator, and others”